By Justin Petrone

More than two years after it first launched a cytogenetics research offering on its SNP 6.0 genotyping array platform, Affymetrix continues to see strong demand for the product, according to a company official.

Richard Shippy, director of product marketing for molecular cytogenetics for the Santa Clara, Calif.-based company, told BioArray News last week that growing interest from cytogeneticists in SNP content has led to a resurgence of sales of Affy's SNP 6.0 chip.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.